CIK: 1241031 - Address: C/o Repligen Corporation, 41 Seyon Street Suite 100, Building 1, Waltham, MA 02453
24 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret112681732199429
P%wins100100100505010083
S%ret1113-0-14018207
S%wins77694646315454

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/19/15 08:05
5/15/15
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPS-62041.3216-15-1397D370135756741311140-3-8-13-37-39
3/25/15 20:05
3/19/15
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPS-48833.3015-15-12112D37411955432722-2-806214020-11
6/11/14 16:51
4/15/14
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPM.ad763.05102519156D4051506037271260-1219-61591
6/10/14 12:09
6/9/14
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPS-60620.1911-30-20121D396148564126103-22017-21286
4/15/14 16:53
4/15/14
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPP.d763.0592520151D123613111-1014-4712266651129
8/9/13 11:39
8/7/13
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPM.d2945.8735057137D185113547262-100-201048113
8/9/13 11:39
8/8/13
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPS.d-30010.013-30-18137D185113547262-100-201048113
3/27/13 17:23
3/26/13
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPM.d1385.5112520147D783815858670630115988
10/2/12 14:15
9/27/12
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPS-305.951-5-3154D8186-240181101-4-17143581
3/28/12 14:45
3/27/12
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPM.d461.8302519159D484568533212138719-19-221726
3/26/12 17:34
3/22/12
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPM.d813.2402521143D362653461752461727-221938
3/31/11 17:35
3/30/11
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPP.d132.6615New5D-23-912-20-236-1-1447-3-1458
12/19/07 14:08
12/13/07
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPS.ad-1236.141-20-9208D8912765474535120-126-28-21-38
12/14/07 15:22
12/13/07
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPM421.411300D10911758444537186-2-110-30-20-36
12/14/07 15:22
12/13/07
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPS-1236.141-20-1000D10911758444537186-2-110-30-20-36
6/18/07 16:48
6/14/07
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPS-293.900-7-1000I91363726118111016115928
3/7/07 16:45
3/5/07
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPS.d-313.050-10-8108D71-28-551-3-3-1-2-2-2124362
3/7/07 16:45
3/7/07
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPM.d301.5002023108D71-28-551-3-3-1-2-2-2124362
12/6/06 16:29
12/5/06
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPS-232.850-8-5142M26-3-7-14-122-3-1-1-1-292191
2/16/06 16:40
2/14/06
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPM.d501.25240631042-3-13-28-20-24
2/16/06 16:40
2/14/06
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPS.d-1254.162-30-221042-3-13-28-20-24
8/4/05 17:09
8/3/05
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPS-353.453-10-577I-501167710367654516-31171148-17
8/2/05 17:24
7/29/05
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPS-302.962-10-1094D-62722262323815-15-1-617-243-30
3/7/05 09:46
3/4/05
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRusche James RMAOSVPM.d251.2502024104D-51-4011-24-27-12-13-4-3-2-325121137

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact